LOS ANGELES CAPITAL MANAGEMENT LLC
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 1177206
LOS ANGELES, CA
Position in HRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,725
-$142,677 QoQ
Shares Held
120,293
-50.5% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 160 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. HRTX ranks #111 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in HRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,725 | 120,293 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $194,402 | 243,003 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $323,137 | 248,567 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $310,480 | 246,413 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $550,884 | 266,128 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $149,166 | 67,803 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $103,509 | 67,653 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $439,459 | 220,834 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $836,146 | 238,899 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,366,341 | 493,264 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $874,440 | 514,377 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $353,420 | 343,127 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $393,789 | 339,474 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,065,572 | 705,677 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $419,132 | 167,653 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $730,283 | 173,053 | Shares | Sole | 2022-11-02 | |
| 2021-03-31 | $258,387 | 15,940 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $543,010 | 25,650 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $380,874 | 25,700 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $359,953 | 24,470 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $178,377 | 15,194 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||